Martha Goldberg Aronson, President and CEO at MERIT MEDICAL SYSTEMS INC (MMSI), bought 2,000 shares at $60.44 ($121K) on 2026-05-06, disclosed to the SEC on 2026-05-07.
Merit Medical Systems CEO Martha Aronson purchased 2,000 shares for $120,880 on May 6, 2026, marking the largest purchase of her career and signaling confidence in the company's valuation. This insider buying comes as the stock trades near its 52-week low, potentially offering a contrarian entry point for traders.
The stock is currently trading at $62.28, down 8.65% over the past five days and 24.51% over the last 90 days, putting it just 3.46% above its 52-week low of $60.20.
Q1 2026 earnings beat estimates with 9% EPS growth and revenue up 7%, while management raised full-year 2026 revenue guidance to $1.61-$1.63 billion on May 14, 2026. Additionally, a cluster of 2 other insiders bought shares in the last 30 days, indicating growing institutional confidence.
The stock faces elevated risk with a short interest of 7.35% of the float, and recent analysis from May 26 cites '2 Reasons to Avoid MMSI' following a 26.3% price decline over the past six months.
Something here stands out, but not much.
| Filing → |
| CSII | BUY | 2021-05-11 | $104K | — | Filing → |
| CSII | BUY | 2020-08-17 | $97K | — | Filing → |
| CSII | BUY | 2018-11-05 | $86K | — | Filing → |